These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 19786120)
1. Interaction between bone morphogenetic proteins and endothelin-1 in human pulmonary artery smooth muscle. Din S; Sarathchandra P; Yacoub MH; Chester AH Vascul Pharmacol; 2009; 51(5-6):344-9. PubMed ID: 19786120 [TBL] [Abstract][Full Text] [Related]
2. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension. Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146 [TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension. Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305 [TBL] [Abstract][Full Text] [Related]
5. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension. Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795 [TBL] [Abstract][Full Text] [Related]
6. Functional characterization of bone morphogenetic protein binding sites and Smad1/5 activation in human vascular cells. Upton PD; Long L; Trembath RC; Morrell NW Mol Pharmacol; 2008 Feb; 73(2):539-52. PubMed ID: 17989347 [TBL] [Abstract][Full Text] [Related]
7. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension. Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886 [TBL] [Abstract][Full Text] [Related]
8. Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice. Long L; MacLean MR; Jeffery TK; Morecroft I; Yang X; Rudarakanchana N; Southwood M; James V; Trembath RC; Morrell NW Circ Res; 2006 Mar; 98(6):818-27. PubMed ID: 16497988 [TBL] [Abstract][Full Text] [Related]
9. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension. Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463 [TBL] [Abstract][Full Text] [Related]
10. Endogenously released endothelin-1 from human pulmonary artery smooth muscle promotes cellular proliferation: relevance to pathogenesis of pulmonary hypertension and vascular remodeling. Wort SJ; Woods M; Warner TD; Evans TW; Mitchell JA Am J Respir Cell Mol Biol; 2001 Jul; 25(1):104-10. PubMed ID: 11472982 [TBL] [Abstract][Full Text] [Related]
11. Altered expression and signal transduction of endothelin-1 receptors in heritable and idiopathic pulmonary arterial hypertension. Yu J; Taylor L; Wilson J; Comhair S; Erzurum S; Polgar P J Cell Physiol; 2013 Feb; 228(2):322-9. PubMed ID: 22688668 [TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells. Yu PB; Beppu H; Kawai N; Li E; Bloch KD J Biol Chem; 2005 Jul; 280(26):24443-50. PubMed ID: 15883158 [TBL] [Abstract][Full Text] [Related]
13. [Bone morphogenetic protein type II receptor gene promoter mutation-142G > A in a patient with familial pulmonary arterial hypertension]. Li W; Hu H Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):230-4. PubMed ID: 19552837 [TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein (BMP) type II receptor is required for BMP-mediated growth arrest and differentiation in pulmonary artery smooth muscle cells. Yu PB; Deng DY; Beppu H; Hong CC; Lai C; Hoyng SA; Kawai N; Bloch KD J Biol Chem; 2008 Feb; 283(7):3877-88. PubMed ID: 18042551 [TBL] [Abstract][Full Text] [Related]
15. ALK2 and BMPR2 knockdown and endothelin-1 production by pulmonary microvascular endothelial cells. Star GP; Giovinazzo M; Langleben D Microvasc Res; 2013 Jan; 85():46-53. PubMed ID: 23142694 [TBL] [Abstract][Full Text] [Related]
16. Expression of bone morphogenetic protein2 (BMP2), BMP4 and BMP receptors in the bovine ovary but absence of effects of BMP2 and BMP4 during IVM on bovine oocyte nuclear maturation and subsequent embryo development. Fatehi AN; van den Hurk R; Colenbrander B; Daemen AJ; van Tol HT; Monteiro RM; Roelen BA; Bevers MM Theriogenology; 2005 Feb; 63(3):872-89. PubMed ID: 15629804 [TBL] [Abstract][Full Text] [Related]
17. Endothelin receptor antagonism in pulmonary arterial hypertension--a role for selective ET(A) inhibition? Jacobs A; Preston IR; Gomberg-Maitland M Curr Med Res Opin; 2006 Dec; 22(12):2567-74. PubMed ID: 17166339 [TBL] [Abstract][Full Text] [Related]
18. Effects of tetrandrine on smooth muscle contraction induced by mediators in pulmonary hypertension. Wang HL; Zhang XH; Chang TH Acta Pharmacol Sin; 2002 Dec; 23(12):1114-20. PubMed ID: 12466049 [TBL] [Abstract][Full Text] [Related]